Cargando…

WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines

BACKGROUND: Invasive lobular carcinoma (ILC) of the breast typically presents with clinical biomarkers consistent with a favorable response to endocrine therapies, and over 90 % of ILC cases express the estrogen receptor (ER). However, a subset of ILC cases may be resistant to endocrine therapies, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikora, Matthew J., Jacobsen, Britta M., Levine, Kevin, Chen, Jian, Davidson, Nancy E., Lee, Adrian V., Alexander, Caroline M., Oesterreich, Steffi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028957/ https://www.ncbi.nlm.nih.gov/pubmed/27650553 http://dx.doi.org/10.1186/s13058-016-0748-7

Ejemplares similares

Estrogen Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular Carcinoma Cell Lines Requires WNT4
por: Shackleford, Madeleine T., et al.
Publicado: (2020)

Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
por: Du, Tian, et al.
Publicado: (2018)

Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
por: Tasdemir, Nilgun, et al.
Publicado: (2020)

Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer
por: Harrell, J. Chuck, et al.
Publicado: (2017)

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
por: Du, Tian, et al.
Publicado: (2018)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

OR09-1 Estrogen Drives Atypical Cell-autonomous WNT4 Signaling In Lobular Carcinoma
por: Ferguson, Rebecca, et al.
Publicado: (2019)

Estradiol as a Targeted, Late-Line Therapy in Metastatic Breast Cancer with Estrogen Receptor Amplification
por: Kota, Karthik, et al.
Publicado: (2017)

Estrogen-repressed genes – key mediators of estrogen action?
por: Zubairy, Simeen, et al.
Publicado: (2005)

Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)

OR07-2 Endocrine Response And Resistance Is Driven By Novel Transcriptional Co-Regulator Activity In Invasive Lobular Carcinoma Of The Breast
por: Costello, James, et al.
Publicado: (2022)

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
por: Levine, Kevin M., et al.
Publicado: (2019)

Non-coding single nucleotide variants affecting estrogen receptor binding and activity
por: Bahreini, Amir, et al.
Publicado: (2016)

OR12-05 MDC1 Is a Novel Estrogen Receptor Co-Regulator in Invasive Lobular Carcinoma of the Breast
por: Bordeaux, Evelyn K, et al.
Publicado: (2020)

How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research
por: Pate, Leigh, et al.
Publicado: (2021)

Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
por: Nunes, Raquel, et al.
Publicado: (2021)

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
por: Sflomos, George, et al.
Publicado: (2021)

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022)

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
por: Yu, Jing, et al.
Publicado: (2023)

Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer
por: Sokol, E S, et al.
Publicado: (2019)

EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer
por: Li, Zheqi, et al.
Publicado: (2023)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Invasive lobular carcinoma of the breast.
por: Hayes, D., et al.
Publicado: (1981)

To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012)

THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
por: Boysen, Michael Rhinehart, et al.
Publicado: (2023)

Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report
por: Toyoshima, Masafumi, et al.
Publicado: (2015)

Estrogen represses gene expression through reconfiguring chromatin structures
por: Osmanbeyoglu, Hatice Ulku, et al.
Publicado: (2013)

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010)

Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
por: Oliveira, Tatiane M. G., et al.
Publicado: (2014)

Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021)

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets
por: Kurozumi, Sasagu, et al.
Publicado: (2020)

Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
por: Blohmer, Martin, et al.
Publicado: (2020)

Epigenetics in breast cancer: what's new?
por: Huang, Yi, et al.
Publicado: (2011)

Mammographically Occult Invasive Lobular Carcinoma With Intradermal Invasion
por: Khanna, Shefali, et al.
Publicado: (2022)

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
por: De Schepper, Maxim, et al.
Publicado: (2022)

Invasive Lobular Carcinoma of the Breast with Extracellular Mucin: Case Report of a New Variant of Lobular Carcinoma of the Breast
por: Boukhechba, M., et al.
Publicado: (2018)

Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
por: Riedlinger, Gregory M., et al.
Publicado: (2021)

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
por: Conforti, Fabio, et al.
Publicado: (2019)

Improved mouse model of invasive lobular carcinoma
Publicado: (2011)

Immune Infiltration in Invasive Lobular Breast Cancer
por: Desmedt, Christine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f5arjje79eaes3g118kl95c5k8